News

#

Saccadic intrusions in paediatric concussion – is there a link to academic performance?

A recent case report study identified saccadic intrusions present only during smooth pursuit and not during fixation, in children 10 to 15 years old who suffered a concussion. Saccadic instructions are involuntary conjugate saccades that interrupt fixation, a common symptom post mTBI. The study concluded that Gabapentin treatment reduced the magnitude of saccadic intrusions and […]

READ MORE
#

Do concussion related deficits in reaction time inform return to activity?

Numerous studies report deficits in reaction time following a concussion, including published research using Neurolign Dx platform devices [1,2]. The recovery time course of reaction time deficits was recently reviewed in “Examination of Reaction Time Deficits Following Concussion: A Systematic Review and Meta-analysis”

READ MORE
#

Presenting at the American Balance Society Annual Meeting March 2020

Join us March 3-4, 2020 in Scottsdale for the American Balance Society Annual Meeting. Explore cutting-edge research and partake in collaborative sessions discussing case studies.

READ MORE
#

Research Leveraging Neurolign published in Race Car Engineer

Neurolign’s Dx 100™ (formerly I-PAS) is leveraged by University of Cambridge researchers in collaboration with the world governing body for motorsport, the FIA [Federation Internationale de l’Automobile], and the FIA Foundation in their first prospective concussion research programme.

READ MORE
#

Neurolign Technologies Inc. to Present at Biotech Showcase™ 2020 in San Fransisco

Neurolign presenting company overview at BioTech Showcase

Toronto, ON, January 8, 2020 – Neurolign Technologies Inc. (“Neurolign”) has scheduled company presentations at Biotech Showcase™ 2020, to be held January 13–15, a critical event for healthcare innovation and investment at the Hilton San Francisco Union Square.

READ MORE
#

Neurolign Technologies Inc. Acquires Neuro Kinetics Inc.

On September 20th, 2019, Neurolign Technologies Inc. (“Neurolign”), announced the acquisition of Neuro Kinetics Inc. (“NKI”) of Pittsburgh, Pennsylvania. Neuro Kinetics Inc. is a leader in its field, providing eye-tracking diagnostic platforms that deliver, leading edge, neuro-functional assessments and monitoring to identify more than 200 diseases and medical conditions (www.neuro-kinetics.com).

READ MORE